Review Article

Impact of the COVID-19 Pandemic on Children and Adolescents with New-Onset Type 1 Diabetes

Table 2

Relative increase of the incidence of type 1 diabetes (T1D) in the COVID-19 pandemic compared to prepandemic periods.

Study regionsData sourcesAge (years)Prepandemic periodPandemic period
PeriodObservedPeriodObservedExpected1Observed vs expectedP
T1D casesT1D casesIncidence (95% CI)2T1D casesIncidence (95% CI)2Relative risk (95% CI)3

Al-Abdulrazzaq 2022 KuwaitChild diabetes registry0.5–≤1224.02.19–23.02.2030324.02.20 –23.02.2132440.2 (36.1, 44.8)30337.6 (33.6, 42.1)1.069 (0.914, 1.250)0.403
Cinek 2022 CzechiaCzech Childhood Diabetes Register<1501.01.10–31.12.1901.01.20–31.12.2195627.2 (25.5, 29.0)82423.4 (21.9, 25.1)1.160 (1.060, 1.280)0.002
Denina 2022 Italy, Piedmont1 pediatric centre≤1415.10.2016–15.04.2017 15.10.2017–15.04.2018 15.10.2018–15.04.20199715.10.20 –15.04.213938.6 (28.2, 52.8)2422.5 (18.5, 27.5)1.711 (1.180, 2.482)0.005
Dilek 2021 South Turkey, Adana1 pediatric centre<1811.03.19–10.03.204611.03.20 –11.03.217411.2 (8.9, 14.1)466.9 (5.2, 9.2)1.623 (1.123, 2.345)0.010
Guo 2022 USA, FloridaOneFlorida + network electronic health records<1801.01.17–31.03.201,92101.04.20 –30.06.212,35432.6 (31.3, 33.9)1,92123.4 (22.7, 24.2)1.392 (1.322, 1.465)<0.001
Hernandez-Herrero 2022 Spain, Tarragona3 pediatric centres<1501.01.18–31.12.195201.01.20 –31.12.203729.1 (21.1, 40.2)2620.4 (15.5, 26.8)1.429 (0.937, 2.178)0.097
Ho 2021 Canada, Alberta2 pediatric centres<1817.03.19–31.08.1911417.03.20 –31.08.201079.9 (8.2, 12.0)11410.6 (8.9, 12.8)0.931 (0.715, 1.212)0.596
Kamrath 2022 GermanyGerman Diabetes Prospective Follow-up Registry0.5–<1801.01.11–31.12.1901.01.20–30.06.215,16224.4 (23.6, 25.2)4,48921.2 (20.5, 21.9)1.150 (1.100, 1.200)<0.001
0.5–<618.6 (17.5, 19.8)15.1 (14.1, 16.2)1.230 (1.130–1.330)<0.001
6–<1232.7 (31.2, 34.3)27.7 (26.3, 29.2)1.180 (1.110–1.260)<0.001
12– < 1823.5 (22.2, 24.8)22.2 (21.0, 23.5)1.060 (0.980–1.130)0.13
Mameli 2021 Italy, Lombardy13 pediatric centres≤1701.01.19–31.12.1923101.01.20 –31.12.2025616.0 (14.2, 18.1)23114.0 (12.9, 15.1)1.143 (0.957, 1.365)0.141
McKeigue 2022 UK, scotlandDiabetes registry≤1401.01.15–31.12.2101.01.20 –31.12.211.200
Pietropaolo 2022TriNetX COVID-19 research network, electronic 60 healthcare organization≤3001.01.18–31.12.1927,70401.03.20–15.07.2121,92530.1 (29.7, 30.5)20,30827.9 (27.6, 28.2)1.080 (1.061, 1.099)<0.001
Pietrzak 2022 Poland14 paediatric centres≤1815.03.19–14.03.201,39115.03.20– 15.03.211,67125.9 (24.7, 27.2)1,39121.6 (20.4, 22.7)1.202 (1.119, 1.290)<0.001
Salmi 2022 FinlandHelsinki University Hospital≤1501.04–31.1023101.04.20–31.10.208456.0 (45.2, 69.3)5838.7 (34.0, 44.0)1.450 (1.130, 1.860)0.004
Shulman 20224 Canada, OntarioHealth insurance data1–1701.01.17–29.02.2001.03.20–30.09.211,57036.7 (35.0, 38.6)1,44033.7 (32.0, 35.5)1.090 (0.910, 1.300)>0.05
VandenBoom 2022 GermanyIQVIA prescription database (LRx)≤2004.01.16−01.03.201629302.03.20−02.01.22749226.7 (26.1, 27.3)599221.2 (20.7, 21.8)1.259 (1.217, 1.303)<0.001
06–083,44706.2020–08.202099025.9 (24.1, 27.8)68918.0 (16.5, 19.6)1.440 (1.130, 1.580)<0.001
In 2016–201905.2021–08.2021103627.1 (25.3, 29.1)62916.5 (15.0, 18.0)1.650 (1.490, 1.820)<0.001
Vlad 20215 RomaniaChild diabetes registry<1501.01.19–31.12.1901.01.20–31.12.2040313.3 (12.1, 14.7)34711.4 (10.3, 12.7)1.166 (1.010, 1.345)0.036

Figures in italics were recalculated based on data reported in the original articles. 1Expected incidences of T1D for the pandemic period under study were estimated from observed incidences for the related prepandemic period. 2Per 100,000 person-years. 3Estimated as ratio of observed and expected incidences. 4No differentiation between type 1 and type 2 diabetes (but 95% of children with diabetes in Ontario have type 1 diabetes). 5To estimate T1D case numbers, we used population data from EUROSTAT (https://ec.europa.eu/eurostat/databrowser/view/DEMO_PJANGROUP__custom_4092331/default/table?lang=en).